The Long-term Effect of Adrenal Arterial Embolization for Unilateral Primary Aldosteronism on Cardiorenovascular Protection, Blood Pressure, and the Endocrinological Profile
Primary aldosteronism (PA) is a major cause of secondary hypertension, divided into two subtypes: unilateral and bilateral. Unilateral PA (u-PA) is surgically-curable. Medical treatment with mineralocorticoid receptors antagonists is recommended as a second-line treatment when the patients are not c...
Gespeichert in:
| Veröffentlicht in: | Internal Medicine 2016, Vol.55(7), pp.769-773 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 773 |
|---|---|
| container_issue | 7 |
| container_start_page | 769 |
| container_title | Internal Medicine |
| container_volume | 55 |
| creator | Kometani, Mitsuhiro Yoneda, Takashi Demura, Masashi Karashima, Shigehiro Mori, Shunsuke Oe, Masashi Sawamura, Toshitaka Okuda, Rika Yamagishi, Masakazu Takeda, Yoshiyu |
| description | Primary aldosteronism (PA) is a major cause of secondary hypertension, divided into two subtypes: unilateral and bilateral. Unilateral PA (u-PA) is surgically-curable. Medical treatment with mineralocorticoid receptors antagonists is recommended as a second-line treatment when the patients are not candidate for surgical treatment. The present case was a 39-year-old woman with u-PA, who had refused surgery, had suffered from adverse effects of medical treatment. She was treated with transcatheter adrenal arterial embolization (TAAE). Her blood pressure had been well controlled without progression of cardiorenovascular damage for 12 years. TAAE can be the third treatment option for u-PA patients. |
| doi_str_mv | 10.2169/internalmedicine.55.5196 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1778708357</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1778708357</sourcerecordid><originalsourceid>FETCH-LOGICAL-c627t-e47c48f546888cc805a1a6c4a9afb0cb3f07b681c9a3f963c44c46af7f0d62593</originalsourceid><addsrcrecordid>eNptkc1u1DAUhS0EokPhFZCXLJrBTuKfLIfRUJBGwKJdRzeOPXXl2MXOVIJ34h1725RZIDa2dc_ncywfQihn65rL7qOPs80RwmRHb3y0ayHWgnfyBVnxpu0qVTfiJVmxjuuqxuWMvCnllrFGq65-Tc5qxVrOZb0if65uLN2neKjQcaI756yZaXJ0M2aLCXSTUfB42E1DCv43zD5F6lKm19EHQBG1H9lPkH_RTRhTwVGKvkwUuS3k0Sd0SvdQzDFARjbNmIEuF_RTSGnEiS3lmO0FhTjSGR-0i2My2ccU0sGbp4DkfLBvySsHodh3z_s5uf68u9p-qfbfL79uN_vKyFrNlW2VabUTrdRaG6OZAA7StNCBG5gZGsfUIDU3HTSuk41pW9NKcMqxUdaia87Jh8X3LqefR1vmfvLF2BAg2nQsPVdKK6YboRDVC2pyKiVb198tn9Fz1j-W1f9bVi9E_1gWXn3_nHIcUDxd_NsOAt8W4LbMcLAnAPLsTbD_dVZP9kvCCTQ3kHsbmwfpr7dE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1778708357</pqid></control><display><type>article</type><title>The Long-term Effect of Adrenal Arterial Embolization for Unilateral Primary Aldosteronism on Cardiorenovascular Protection, Blood Pressure, and the Endocrinological Profile</title><source>MEDLINE</source><source>J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Kometani, Mitsuhiro ; Yoneda, Takashi ; Demura, Masashi ; Karashima, Shigehiro ; Mori, Shunsuke ; Oe, Masashi ; Sawamura, Toshitaka ; Okuda, Rika ; Yamagishi, Masakazu ; Takeda, Yoshiyu</creator><creatorcontrib>Kometani, Mitsuhiro ; Yoneda, Takashi ; Demura, Masashi ; Karashima, Shigehiro ; Mori, Shunsuke ; Oe, Masashi ; Sawamura, Toshitaka ; Okuda, Rika ; Yamagishi, Masakazu ; Takeda, Yoshiyu</creatorcontrib><description>Primary aldosteronism (PA) is a major cause of secondary hypertension, divided into two subtypes: unilateral and bilateral. Unilateral PA (u-PA) is surgically-curable. Medical treatment with mineralocorticoid receptors antagonists is recommended as a second-line treatment when the patients are not candidate for surgical treatment. The present case was a 39-year-old woman with u-PA, who had refused surgery, had suffered from adverse effects of medical treatment. She was treated with transcatheter adrenal arterial embolization (TAAE). Her blood pressure had been well controlled without progression of cardiorenovascular damage for 12 years. TAAE can be the third treatment option for u-PA patients.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.55.5196</identifier><identifier>PMID: 27041162</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>adrenal arterial embolization ; Adult ; Blood Pressure - drug effects ; Embolization, Therapeutic - methods ; Female ; Humans ; Hyperaldosteronism - complications ; Hyperaldosteronism - metabolism ; Hyperaldosteronism - physiopathology ; Hyperaldosteronism - therapy ; Mineralocorticoid Receptor Antagonists - therapeutic use ; primary aldosteronism ; Treatment Outcome</subject><ispartof>Internal Medicine, 2016, Vol.55(7), pp.769-773</ispartof><rights>2016 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c627t-e47c48f546888cc805a1a6c4a9afb0cb3f07b681c9a3f963c44c46af7f0d62593</citedby><cites>FETCH-LOGICAL-c627t-e47c48f546888cc805a1a6c4a9afb0cb3f07b681c9a3f963c44c46af7f0d62593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27041162$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kometani, Mitsuhiro</creatorcontrib><creatorcontrib>Yoneda, Takashi</creatorcontrib><creatorcontrib>Demura, Masashi</creatorcontrib><creatorcontrib>Karashima, Shigehiro</creatorcontrib><creatorcontrib>Mori, Shunsuke</creatorcontrib><creatorcontrib>Oe, Masashi</creatorcontrib><creatorcontrib>Sawamura, Toshitaka</creatorcontrib><creatorcontrib>Okuda, Rika</creatorcontrib><creatorcontrib>Yamagishi, Masakazu</creatorcontrib><creatorcontrib>Takeda, Yoshiyu</creatorcontrib><title>The Long-term Effect of Adrenal Arterial Embolization for Unilateral Primary Aldosteronism on Cardiorenovascular Protection, Blood Pressure, and the Endocrinological Profile</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>Primary aldosteronism (PA) is a major cause of secondary hypertension, divided into two subtypes: unilateral and bilateral. Unilateral PA (u-PA) is surgically-curable. Medical treatment with mineralocorticoid receptors antagonists is recommended as a second-line treatment when the patients are not candidate for surgical treatment. The present case was a 39-year-old woman with u-PA, who had refused surgery, had suffered from adverse effects of medical treatment. She was treated with transcatheter adrenal arterial embolization (TAAE). Her blood pressure had been well controlled without progression of cardiorenovascular damage for 12 years. TAAE can be the third treatment option for u-PA patients.</description><subject>adrenal arterial embolization</subject><subject>Adult</subject><subject>Blood Pressure - drug effects</subject><subject>Embolization, Therapeutic - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Hyperaldosteronism - complications</subject><subject>Hyperaldosteronism - metabolism</subject><subject>Hyperaldosteronism - physiopathology</subject><subject>Hyperaldosteronism - therapy</subject><subject>Mineralocorticoid Receptor Antagonists - therapeutic use</subject><subject>primary aldosteronism</subject><subject>Treatment Outcome</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkc1u1DAUhS0EokPhFZCXLJrBTuKfLIfRUJBGwKJdRzeOPXXl2MXOVIJ34h1725RZIDa2dc_ncywfQihn65rL7qOPs80RwmRHb3y0ayHWgnfyBVnxpu0qVTfiJVmxjuuqxuWMvCnllrFGq65-Tc5qxVrOZb0if65uLN2neKjQcaI756yZaXJ0M2aLCXSTUfB42E1DCv43zD5F6lKm19EHQBG1H9lPkH_RTRhTwVGKvkwUuS3k0Sd0SvdQzDFARjbNmIEuF_RTSGnEiS3lmO0FhTjSGR-0i2My2ccU0sGbp4DkfLBvySsHodh3z_s5uf68u9p-qfbfL79uN_vKyFrNlW2VabUTrdRaG6OZAA7StNCBG5gZGsfUIDU3HTSuk41pW9NKcMqxUdaia87Jh8X3LqefR1vmfvLF2BAg2nQsPVdKK6YboRDVC2pyKiVb198tn9Fz1j-W1f9bVi9E_1gWXn3_nHIcUDxd_NsOAt8W4LbMcLAnAPLsTbD_dVZP9kvCCTQ3kHsbmwfpr7dE</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Kometani, Mitsuhiro</creator><creator>Yoneda, Takashi</creator><creator>Demura, Masashi</creator><creator>Karashima, Shigehiro</creator><creator>Mori, Shunsuke</creator><creator>Oe, Masashi</creator><creator>Sawamura, Toshitaka</creator><creator>Okuda, Rika</creator><creator>Yamagishi, Masakazu</creator><creator>Takeda, Yoshiyu</creator><general>The Japanese Society of Internal Medicine</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160101</creationdate><title>The Long-term Effect of Adrenal Arterial Embolization for Unilateral Primary Aldosteronism on Cardiorenovascular Protection, Blood Pressure, and the Endocrinological Profile</title><author>Kometani, Mitsuhiro ; Yoneda, Takashi ; Demura, Masashi ; Karashima, Shigehiro ; Mori, Shunsuke ; Oe, Masashi ; Sawamura, Toshitaka ; Okuda, Rika ; Yamagishi, Masakazu ; Takeda, Yoshiyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c627t-e47c48f546888cc805a1a6c4a9afb0cb3f07b681c9a3f963c44c46af7f0d62593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>adrenal arterial embolization</topic><topic>Adult</topic><topic>Blood Pressure - drug effects</topic><topic>Embolization, Therapeutic - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Hyperaldosteronism - complications</topic><topic>Hyperaldosteronism - metabolism</topic><topic>Hyperaldosteronism - physiopathology</topic><topic>Hyperaldosteronism - therapy</topic><topic>Mineralocorticoid Receptor Antagonists - therapeutic use</topic><topic>primary aldosteronism</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kometani, Mitsuhiro</creatorcontrib><creatorcontrib>Yoneda, Takashi</creatorcontrib><creatorcontrib>Demura, Masashi</creatorcontrib><creatorcontrib>Karashima, Shigehiro</creatorcontrib><creatorcontrib>Mori, Shunsuke</creatorcontrib><creatorcontrib>Oe, Masashi</creatorcontrib><creatorcontrib>Sawamura, Toshitaka</creatorcontrib><creatorcontrib>Okuda, Rika</creatorcontrib><creatorcontrib>Yamagishi, Masakazu</creatorcontrib><creatorcontrib>Takeda, Yoshiyu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kometani, Mitsuhiro</au><au>Yoneda, Takashi</au><au>Demura, Masashi</au><au>Karashima, Shigehiro</au><au>Mori, Shunsuke</au><au>Oe, Masashi</au><au>Sawamura, Toshitaka</au><au>Okuda, Rika</au><au>Yamagishi, Masakazu</au><au>Takeda, Yoshiyu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Long-term Effect of Adrenal Arterial Embolization for Unilateral Primary Aldosteronism on Cardiorenovascular Protection, Blood Pressure, and the Endocrinological Profile</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>55</volume><issue>7</issue><spage>769</spage><epage>773</epage><pages>769-773</pages><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>Primary aldosteronism (PA) is a major cause of secondary hypertension, divided into two subtypes: unilateral and bilateral. Unilateral PA (u-PA) is surgically-curable. Medical treatment with mineralocorticoid receptors antagonists is recommended as a second-line treatment when the patients are not candidate for surgical treatment. The present case was a 39-year-old woman with u-PA, who had refused surgery, had suffered from adverse effects of medical treatment. She was treated with transcatheter adrenal arterial embolization (TAAE). Her blood pressure had been well controlled without progression of cardiorenovascular damage for 12 years. TAAE can be the third treatment option for u-PA patients.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>27041162</pmid><doi>10.2169/internalmedicine.55.5196</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0918-2918 |
| ispartof | Internal Medicine, 2016, Vol.55(7), pp.769-773 |
| issn | 0918-2918 1349-7235 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1778708357 |
| source | MEDLINE; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese; PubMed Central; PubMed Central Open Access |
| subjects | adrenal arterial embolization Adult Blood Pressure - drug effects Embolization, Therapeutic - methods Female Humans Hyperaldosteronism - complications Hyperaldosteronism - metabolism Hyperaldosteronism - physiopathology Hyperaldosteronism - therapy Mineralocorticoid Receptor Antagonists - therapeutic use primary aldosteronism Treatment Outcome |
| title | The Long-term Effect of Adrenal Arterial Embolization for Unilateral Primary Aldosteronism on Cardiorenovascular Protection, Blood Pressure, and the Endocrinological Profile |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T10%3A36%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Long-term%20Effect%20of%20Adrenal%20Arterial%20Embolization%20for%20Unilateral%20Primary%20Aldosteronism%20on%20Cardiorenovascular%20Protection,%20Blood%20Pressure,%20and%20the%20Endocrinological%20Profile&rft.jtitle=Internal%20Medicine&rft.au=Kometani,%20Mitsuhiro&rft.date=2016-01-01&rft.volume=55&rft.issue=7&rft.spage=769&rft.epage=773&rft.pages=769-773&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.55.5196&rft_dat=%3Cproquest_cross%3E1778708357%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1778708357&rft_id=info:pmid/27041162&rfr_iscdi=true |